• Strategy
  • Payers
  • AI
  • Cybersecurity
  • Device Development
  • Studies/Published Research
  • Ethics
  • Regulatory
  • Digital Biomarkers
  • Data Science
  • Companion Diagnostics
  • Clinical Care
  • Digital Therapeutics
  • Academic Research
  • Virtual Reality
  • RWE
  • Digital Endpoints
  • Medical Devices (Class II and Class III)
  • Commercialization
  • Clinical Trials
  • Drug-Device Combinations
  • SaMD
  • Remote Patient Monitoring
  • Patient Engagement
  • Profiles/Q&A

Ceribell Names Joshua Copp as Chief Operating Officer


Copp comes to the company from McKinsey & Co.

Ceribell announced that it has named Joshua Copp as its new chief operating officer.

In a press release, Ceribell co-founder and CEO Jane Chao, PhD, said, “Joshua's leadership within McKinsey & Co.'s Medical Device Division provides him with a wealth of expertise that he will now bring to our team. His professional experience driving growth and shaping markets with clients aligns seamlessly with Ceribell's vision to make Ceribell the standard of care in seizure management."

Ceribell developed an AI-powered point-of-care EEG diagnostic system and is working to improve seizure management in acute care.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.